Christopher David Brook, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laryngoscopy | 9 | 2023 | 714 | 2.460 |
Why?
|
Nasal Polyps | 6 | 2024 | 409 | 1.880 |
Why?
|
Rhinitis | 8 | 2024 | 751 | 1.600 |
Why?
|
Sinusitis | 8 | 2024 | 995 | 1.570 |
Why?
|
Otolaryngology | 5 | 2020 | 701 | 1.520 |
Why?
|
Allergens | 6 | 2023 | 1441 | 1.070 |
Why?
|
Hypersensitivity | 6 | 2021 | 1173 | 0.920 |
Why?
|
Papilloma, Inverted | 1 | 2023 | 19 | 0.890 |
Why?
|
Documentation | 2 | 2020 | 917 | 0.860 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2023 | 243 | 0.840 |
Why?
|
Liver Failure | 1 | 2023 | 252 | 0.760 |
Why?
|
Nose Neoplasms | 1 | 2023 | 250 | 0.740 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 250 | 0.740 |
Why?
|
Nasal Decongestants | 1 | 2019 | 29 | 0.680 |
Why?
|
Medical Record Administrators | 1 | 2019 | 4 | 0.670 |
Why?
|
Laryngitis | 2 | 2016 | 27 | 0.650 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2020 | 119 | 0.650 |
Why?
|
Paranasal Sinuses | 2 | 2017 | 266 | 0.570 |
Why?
|
Patient Satisfaction | 2 | 2019 | 3486 | 0.540 |
Why?
|
Eustachian Tube | 1 | 2017 | 99 | 0.530 |
Why?
|
Otitis Media with Effusion | 1 | 2017 | 115 | 0.530 |
Why?
|
Angioedema | 2 | 2017 | 184 | 0.530 |
Why?
|
Ambulatory Care Facilities | 2 | 2019 | 941 | 0.530 |
Why?
|
Meniere Disease | 1 | 2017 | 164 | 0.520 |
Why?
|
Cranial Sinuses | 1 | 2015 | 68 | 0.470 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2014 | 60 | 0.460 |
Why?
|
Orbital Diseases | 1 | 2016 | 178 | 0.460 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 450 | 0.440 |
Why?
|
Mouth | 1 | 2016 | 383 | 0.440 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1397 | 0.440 |
Why?
|
Jugular Veins | 1 | 2015 | 211 | 0.440 |
Why?
|
Neck Dissection | 1 | 2015 | 201 | 0.430 |
Why?
|
Desensitization, Immunologic | 1 | 2018 | 559 | 0.420 |
Why?
|
Abscess | 1 | 2016 | 606 | 0.410 |
Why?
|
Telemedicine | 2 | 2020 | 3107 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.400 |
Why?
|
Electronic Health Records | 3 | 2022 | 4875 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.400 |
Why?
|
Immunoglobulin E | 4 | 2024 | 1506 | 0.390 |
Why?
|
Endoscopy | 6 | 2024 | 1857 | 0.370 |
Why?
|
Chronic Disease | 10 | 2024 | 9379 | 0.370 |
Why?
|
Nose | 1 | 2014 | 523 | 0.360 |
Why?
|
Respiratory System | 1 | 2014 | 565 | 0.350 |
Why?
|
Urban Population | 1 | 2018 | 2045 | 0.350 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1066 | 0.330 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1517 | 0.330 |
Why?
|
Adenoidectomy | 2 | 2020 | 170 | 0.310 |
Why?
|
Airway Obstruction | 1 | 2014 | 672 | 0.310 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2412 | 0.310 |
Why?
|
Turbinates | 2 | 2018 | 66 | 0.300 |
Why?
|
Aerosols | 2 | 2021 | 637 | 0.300 |
Why?
|
Internship and Residency | 3 | 2020 | 5949 | 0.290 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1285 | 0.280 |
Why?
|
Skin Tests | 2 | 2021 | 639 | 0.280 |
Why?
|
Medication Adherence | 1 | 2018 | 2189 | 0.270 |
Why?
|
Otitis Media | 2 | 2020 | 288 | 0.250 |
Why?
|
Intubation, Intratracheal | 1 | 2014 | 1359 | 0.250 |
Why?
|
Bacteria | 1 | 2016 | 2221 | 0.250 |
Why?
|
Retrospective Studies | 16 | 2023 | 81801 | 0.240 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.230 |
Why?
|
Foreign Bodies | 2 | 2021 | 403 | 0.230 |
Why?
|
Stroboscopy | 1 | 2023 | 62 | 0.220 |
Why?
|
Clinical Competence | 2 | 2020 | 4848 | 0.220 |
Why?
|
Iron-Dextran Complex | 1 | 2023 | 14 | 0.220 |
Why?
|
Blood Sedimentation | 1 | 2024 | 235 | 0.210 |
Why?
|
Humans | 41 | 2024 | 768393 | 0.180 |
Why?
|
Nasal Cavity | 2 | 2020 | 311 | 0.180 |
Why?
|
Cell Adhesion Molecules | 2 | 2017 | 1614 | 0.180 |
Why?
|
Adenoids | 1 | 2020 | 35 | 0.170 |
Why?
|
Biological Therapy | 1 | 2021 | 140 | 0.170 |
Why?
|
Endoscopes | 1 | 2020 | 169 | 0.160 |
Why?
|
Inflammation | 2 | 2020 | 10863 | 0.150 |
Why?
|
Preoperative Care | 2 | 2024 | 2258 | 0.150 |
Why?
|
Administration, Topical | 1 | 2019 | 703 | 0.140 |
Why?
|
Teaching Materials | 1 | 2017 | 86 | 0.140 |
Why?
|
Age Factors | 1 | 2014 | 18471 | 0.140 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 687 | 0.140 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2017 | 53 | 0.140 |
Why?
|
Fiber Optic Technology | 2 | 2017 | 291 | 0.130 |
Why?
|
Dacryocystorhinostomy | 1 | 2017 | 78 | 0.130 |
Why?
|
Asthma | 4 | 2020 | 6280 | 0.130 |
Why?
|
Tissue Adhesions | 1 | 2017 | 223 | 0.130 |
Why?
|
Esophagus | 1 | 2021 | 1042 | 0.120 |
Why?
|
Lacrimal Apparatus | 1 | 2017 | 223 | 0.120 |
Why?
|
Adult | 17 | 2024 | 223640 | 0.120 |
Why?
|
Ear Diseases | 1 | 2016 | 181 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2019 | 22296 | 0.120 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 219 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 985 | 0.110 |
Why?
|
Autonomic Nervous System | 1 | 2018 | 709 | 0.110 |
Why?
|
Pharynx | 1 | 2015 | 436 | 0.100 |
Why?
|
Immunization | 1 | 2017 | 1219 | 0.100 |
Why?
|
Male | 18 | 2024 | 364902 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3857 | 0.100 |
Why?
|
Speech | 1 | 2017 | 558 | 0.100 |
Why?
|
Video Recording | 1 | 2017 | 974 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 223491 | 0.090 |
Why?
|
Comorbidity | 2 | 2017 | 10588 | 0.090 |
Why?
|
Female | 17 | 2024 | 397089 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8753 | 0.090 |
Why?
|
Radiography | 1 | 2021 | 6993 | 0.090 |
Why?
|
Postoperative Period | 1 | 2015 | 1830 | 0.080 |
Why?
|
Adenoma, Pleomorphic | 1 | 2010 | 77 | 0.080 |
Why?
|
Skull Neoplasms | 1 | 2010 | 173 | 0.080 |
Why?
|
Facial Injuries | 1 | 2010 | 191 | 0.070 |
Why?
|
Adolescent | 5 | 2020 | 89184 | 0.070 |
Why?
|
Hypertrophy | 2 | 2020 | 562 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9371 | 0.070 |
Why?
|
Time Factors | 2 | 2019 | 40272 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15881 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3267 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3813 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2783 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7242 | 0.060 |
Why?
|
Massachusetts | 1 | 2018 | 8902 | 0.060 |
Why?
|
Temporal Bone | 1 | 2010 | 683 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2019 | 59686 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 20765 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2842 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 13020 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9636 | 0.060 |
Why?
|
Nasal Lavage | 1 | 2024 | 17 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7861 | 0.060 |
Why?
|
Young Adult | 3 | 2019 | 60049 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15455 | 0.050 |
Why?
|
Carcinoma | 1 | 2015 | 2341 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 2 | 2018 | 326 | 0.050 |
Why?
|
Therapeutic Irrigation | 1 | 2024 | 297 | 0.050 |
Why?
|
Sex Factors | 1 | 2017 | 10654 | 0.050 |
Why?
|
Preoperative Period | 1 | 2024 | 564 | 0.050 |
Why?
|
Numismatics | 1 | 2021 | 16 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8731 | 0.050 |
Why?
|
Sneezing | 1 | 2021 | 17 | 0.050 |
Why?
|
Risk Factors | 4 | 2017 | 74962 | 0.050 |
Why?
|
United States | 3 | 2018 | 73150 | 0.050 |
Why?
|
Aged | 5 | 2024 | 171562 | 0.040 |
Why?
|
Electric Power Supplies | 1 | 2021 | 96 | 0.040 |
Why?
|
Child, Preschool | 3 | 2020 | 42650 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2013 | 1881 | 0.040 |
Why?
|
Histamine Antagonists | 1 | 2020 | 94 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6881 | 0.040 |
Why?
|
Palliative Care | 1 | 2015 | 3643 | 0.040 |
Why?
|
Athletic Injuries | 1 | 2010 | 1245 | 0.040 |
Why?
|
Eosinophils | 1 | 2024 | 953 | 0.040 |
Why?
|
Steroids | 1 | 2024 | 937 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 485 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 41795 | 0.040 |
Why?
|
Reoperation | 2 | 2020 | 4341 | 0.040 |
Why?
|
Sodium Chloride | 1 | 2020 | 584 | 0.040 |
Why?
|
Tonsillectomy | 1 | 2020 | 280 | 0.030 |
Why?
|
Cough | 1 | 2021 | 599 | 0.030 |
Why?
|
Cadaver | 1 | 2021 | 1366 | 0.030 |
Why?
|
Algorithms | 2 | 2015 | 14154 | 0.030 |
Why?
|
Nasal Obstruction | 1 | 2018 | 163 | 0.030 |
Why?
|
Disease Management | 2 | 2018 | 2537 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20224 | 0.030 |
Why?
|
Patients | 1 | 2022 | 909 | 0.030 |
Why?
|
Child | 3 | 2020 | 80891 | 0.030 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 58 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2017 | 1169 | 0.030 |
Why?
|
Sphenoid Sinus | 1 | 2015 | 101 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1191 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 54920 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2014 | 7955 | 0.030 |
Why?
|
Equipment Design | 1 | 2021 | 3529 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 30228 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 829 | 0.020 |
Why?
|
Chemoprevention | 1 | 2013 | 326 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2663 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2168 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 65379 | 0.020 |
Why?
|
Physical Examination | 1 | 2015 | 1262 | 0.020 |
Why?
|
Particulate Matter | 1 | 2021 | 2609 | 0.020 |
Why?
|
Eating | 1 | 2015 | 1541 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8506 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21544 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21162 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14737 | 0.020 |
Why?
|
Osteotomy | 1 | 2010 | 838 | 0.010 |
Why?
|
Inpatients | 1 | 2013 | 2570 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7463 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16721 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39407 | 0.010 |
Why?
|
Hospitalization | 1 | 2013 | 10844 | 0.010 |
Why?
|